7.77新台幣0.09(1.17%)
2022/08/10更新
績效 / 1月0.39%
3月5.71%
1年30.75%
晨星評等-
- 1.現金12.78%
- 2.股票20.93%
- 3.債券0.00%
- 4.其他66.29%
- 1.美國64.29%
- 2.新興亞洲9.46%
- 3.已開發亞洲7.21%
- 4.日本2.84%
- 5.歐洲不包含歐元區0.83%
- 1.健康護理73.62%
- 2.防守性消費5.19%
- 3.基本物料3.44%
- 4.科技1.56%
- 5.電訊服務1.17%
- 6.周期性消費0.25%
- 1.Bristol-Myers Squibb Co6.22%
- 2.AbbVie Inc6.17%
- 3.UnitedHealth Group Inc6.04%
- 4.Johnson & Johnson5.67%
- 5.Regeneron Pharmaceuticals Inc4.67%
- 6.Seagen Inc Ordinary Shares4.08%
- 7.Eli Lilly and Co3.60%
- 8.Lotus Pharmaceutical Co Ltd3.16%
- 9.Vertex Pharmaceuticals Inc3.13%
- 10.Pfizer Inc3.00%
- 1.現金12.78%
- 2.股票20.93%
- 3.債券0.00%
- 4.其他66.29%
- 1.健康護理73.62%
- 2.防守性消費5.19%
- 3.基本物料3.44%
- 4.科技1.56%
- 5.電訊服務1.17%
- 6.周期性消費0.25%
- 1.美國64.29%
- 2.新興亞洲9.46%
- 3.已開發亞洲7.21%
- 4.日本2.84%
- 5.歐洲不包含歐元區0.83%
- 1.Bristol-Myers Squibb Co6.22%
- 2.AbbVie Inc6.17%
- 3.UnitedHealth Group Inc6.04%
- 4.Johnson & Johnson5.67%
- 5.Regeneron Pharmaceuticals Inc4.67%
- 6.Seagen Inc Ordinary Shares4.08%
- 7.Eli Lilly and Co3.60%
- 8.Lotus Pharmaceutical Co Ltd3.16%
- 9.Vertex Pharmaceuticals Inc3.13%
- 10.Pfizer Inc3.00%